Melatonin increases the chemosensitivity of diffuse large B-cell lymphoma cells to epirubicin by inhibiting P-glycoprotein expression via the NF-κB pathway

BACKGROUND: Epirubicin is a first-line chemotherapeutic drug for the clinical treatment of diffuse large B cell lymphoma (DLBCL), but the overexpression of multidrug resistance (MDR) transporter proteins, especially P-glycoprotein (P-gp), renders epirubicin ineffective. Some studies reveal the poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kaili, Song, Jincheng, Yan, Yue, Zou, Kun, Che, Yuxuan, Wang, Beichen, Li, Zongjuan, Yu, Wendan, Guo, Wei, Zou, Lijuan, Deng, Wuguo, Sun, Xiuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527585/
https://www.ncbi.nlm.nih.gov/pubmed/33007707
http://dx.doi.org/10.1016/j.tranon.2020.100876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527585/
https://www.ncbi.nlm.nih.gov/pubmed/33007707
http://dx.doi.org/10.1016/j.tranon.2020.100876

Ejemplares similares